PTC Therapeutics
PTCT
PTCT
177 hedge funds and large institutions have $3B invested in PTC Therapeutics in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 54 increasing their positions, 65 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
2% less funds holding
Funds holding: 181 → 177 (-4)
17% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 65
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
177
Holding in Top 10
4
Calls
$1.86M
Puts
$2.03M
Top Buyers
| 1 | +$93.7M | |
| 2 | +$13M | |
| 3 | +$11.9M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$9.88M |
| 5 |
Morgan Stanley
New York
|
+$6.92M |
Top Sellers
| 1 | -$66.9M | |
| 2 | -$24.4M | |
| 3 | -$8.04M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.54M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$5.36M |